Your browser doesn't support javascript.
loading
Endogenous stimuli-responsive nanoparticles for cancer therapy: From bench to bedside.
Xie, Feiyu; Wang, Mina; Chen, Qishuang; Chi, Tiange; Zhu, Shijie; Wei, Peng; Yang, Yingying; Zhang, Le; Li, Xuexin; Liao, Zehuan.
Affiliation
  • Xie F; Graduate School, Beijing University of Chinese Medicine, Beijing 100029, China; Oncology Department, Wangjing Hospital of China Academy of Chinese Medical Sciences, Beijing 100102, China.
  • Wang M; Graduate School, Beijing University of Chinese Medicine, Beijing 100029, China; Department of Acupuncture and Moxibustion, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing Key Laboratory of Acupuncture Neuromodulation, Beijing 100010, China.
  • Chen Q; Graduate School, Beijing University of Chinese Medicine, Beijing 100029, China; Department of Integrative Oncology, China-Japan Friendship Hospital, Beijing 100029, China.
  • Chi T; Key Laboratory of Growth Regulation and Translational Research of Zhejiang Province, School of Life Sciences, Westlake University, Zhejiang 310024, China.
  • Zhu S; Oncology Department, Wangjing Hospital of China Academy of Chinese Medical Sciences, Beijing 100102, China.
  • Wei P; School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China.
  • Yang Y; Clinical Research Center, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternaity and Infant Hospital, School of Medicine, Tongji University, Shanghai 201204, China.
  • Zhang L; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna 17165, Sweden.
  • Li X; Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Solna 17165, Sweden. Electronic address: Xuexin.li@ki.se.
  • Liao Z; School of Biological Sciences, Nanyang Technological University, Singapore 637551, Singapore; Department of Microbiology, Tumor, and Cell Biology (MTC), Karolinska Institutet, Stockholm 17177, Sweden. Electronic address: Liao0058@e.ntu.edu.sg.
Pharmacol Res ; 186: 106522, 2022 12.
Article in En | MEDLINE | ID: mdl-36283629
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nanoparticles / Neoplasms / Antineoplastic Agents Limits: Humans Language: En Journal: Pharmacol Res Journal subject: FARMACOLOGIA Year: 2022 Type: Article Affiliation country: China
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Nanoparticles / Neoplasms / Antineoplastic Agents Limits: Humans Language: En Journal: Pharmacol Res Journal subject: FARMACOLOGIA Year: 2022 Type: Article Affiliation country: China